Navigation Links
Eric Tardif Joins Gen-Probe as Senior Vice President, Corporate Strategy
Date:1/13/2009

SAN DIEGO, Jan. 13 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that Eric Tardif has joined the Company as senior vice president, corporate strategy.

"We are delighted to add someone of Eric's caliber and experience to our already strong senior management team," said Hank Nordhoff, Gen-Probe's chairman and chief executive officer. "We believe he will have an immediate impact on our corporate planning and development activities."

Mr. Tardif, 39, was formerly a managing director in Morgan Stanley's healthcare investment banking group, where he advised diagnostics, life sciences tools, and medical technology companies on corporate strategy, mergers and acquisitions, and financing activities. Before joining Morgan Stanley, he was a principal in Piper Jaffray's healthcare investment banking group.

Mr. Tardif holds a chartered financial analyst (CFA) designation. He earned a BA in business from Bishop's University in Quebec, an MBA from the University of British Columbia, and an MS in finance from the Carroll Graduate School of Management at Boston College.

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has more than 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release relating to expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as believe, will, expect, anticipate, estimate, intend, plan and would. For example, statements regarding the plans and objectives of management are forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied. Some of these risks include, but are not limited to, the risk that we cannot retain key executives. For additional information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we file with the SEC, including our most recent annual report on Form 10-K and all subsequent periodic reports. We assume no obligation and expressly disclaim any duty to update forward-looking statements to reflect events or circumstances after the date of this news release or to reflect the occurrence of subsequent events.

    Contact:

    Michael Watts
    Senior director, investor relations and
    corporate communications
    858-410-8673


'/>"/>
SOURCE Gen-Probe Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Richard Greco Joins Mediware Board
2. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
3. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
4. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
5. Nick Childs Joins Grey New York as Director of Content Development
6. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
7. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
8. NASN Joins Partnership to Fight Chronic Disease
9. AstraZeneca Joins Local Walking Movement
10. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
11. Fund Manager Joins Board of GSI Securitization Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... Adolfson & Peterson Construction ... the Ramsey County Medical Examiners Facility located in Saint Paul, Minn. A single ... is scheduled to start in late 2017/early 2018. , Staffed by 20 ...
(Date:7/21/2017)... ONTARIO, CANADA (PRWEB) , ... July 21, 2017 , ... ... IL and Past President of the American Orthopaedic Society of Sports Medicine (AOSSM) ... 21, 2017 during the AOSSM Annual Meeting in Toronto, Canada. This prestigious award is ...
(Date:7/21/2017)... ... July 21, 2017 , ... MedMatchPlus+ has launched ... of acceptance to a residency in a United States hospital. Being accepted into ... U.S. , According to data released by the ECFMG®, every year, 50 percent ...
(Date:7/21/2017)... , ... July 21, 2017 , ... ... at 10 years, researchers from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that ... a decade after surgery, though activity levels decline over time. The study, presented ...
(Date:7/20/2017)... Va. (PRWEB) , ... July 20, 2017 , ... ... McCarter, MD, has joined JenCare Senior Medical Center as Richmond Chief Medical ... Virginia School of Medicine, and Associate Chief Medical Officer of Ambulatory Services for the ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... RK Logistics Group, Inc. was awarded ... Fremont, CA headquarters facility where it ... San Jose for hi-tech, pharmaceutical and ... , with its Fremont Innovation District, is excited to strategically ... resource to the hundreds of biotech, pharma and biomed companies ...
(Date:7/11/2017)... 11, 2017 Zymo Research Corp., also known as ,The Epigenetics ... biological aging in a precise manner using the myDNAge ™ test. ... a professor of human genetics and biostatistics at the David Geffen ... Health , Zymo Research,s proprietary DNAge ™ technology is used to ... ...
(Date:7/11/2017)... , July 11, 2017  Dr. Echenberg, founder of Echenberg Institute, is ... to patients who suffer from painful intercourse and other painful pelvic pain ... atrophy due to menopause. ... VuVatech LLC ... by Sarasota, Florida -based start-up company, VuVatech LLC, fills ...
Breaking Medicine Technology: